SCHEMBL7101540

SCHEMBL7101540

N#Cc1ccc(-c2ccccc2C(C(N)=O)c2cccc(C#N)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.47
IRAK4 Q9NWZ3 1/20 0.41
ADRA1D P25100 4/20 0.39
ADRA1A P35348 2/20 0.39
ADRA2B P18089 1/20 0.39
ADRA1B P35368 1/20 0.39
HPGDS O60760 1/20 0.38
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37
MAOB P27338 2/20 0.37
PARP1 P09874 1/20 0.37
GRM4 Q14833 1/20 0.37
PTGDR2 Q9Y5Y4 1/20 0.36
TOP2A P11388 1/20 0.36
TOP2B Q02880 1/20 0.36
GSK3B P49841 1/20 0.36
XDH P47989 1/20 0.36
SLC22A12 Q96S37 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6165960 0.91 TNF (0.48) TNFADRA1DADRA1AADRA2BADRA1B
SCHEMBL6167048 0.88 IRAK4 (0.40) TNFIRAK4MEN1KMT2AMAOB
SCHEMBL7108450 0.88 ADRA2C (0.44) TNFIRAK4HPGDSMEN1ALDH1A1
SCHEMBL6164469 0.86 HPGDS (0.46) TNFADRA1DADRA2BHPGDSMAOB
SCHEMBL20529655 0.72 MEN1 (0.49) MEN1ALDH1A1MAPTKMT2AMAOB
SCHEMBL6164919 0.70 GRM4 (0.48) TNFHPGDSALDH1A1MAPTGRM4
SCHEMBL6390843 0.70 TNF (0.52) TNFADRA1DADRA1AADRA2BADRA1B
SCHEMBL934609 0.69 ADRA1D (0.50) TNFADRA1DADRA1AADRA2BADRA1B
SCHEMBL1706248 0.68 ADRA1D (0.49) TNFADRA1DADRA1AADRA2BADRA1B
SCHEMBL28045856 0.68 BCAT2 (0.65) IRAK4ALDH1A1MAPTMAOBPARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065176-A1 Factor xa inhibitors with aryl-amidines and derivatives, and prodrugs thereof LG CHEM INVESTMENT LTD. (KR) 2003-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065176-A1 Factor xa inhibitors with aryl-amidines and derivatives, and prodrugs thereof F2, F12, TFPI TNF 2693/4885IRAK4 4257/4885ADRA1D 1745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.